Zachary S. Aman

Zachary S. Aman

Auto-generated profile, based on publicly available information

Zachary S. Aman

Department of Orthopedic Surgery, Duke University, Durham, North Carolina, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2021 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
TDTravis J. Dekker
Travis J. Dekker
ZAZachary S. Aman
Zachary S. Aman
NDNicholas N. DePhillipo
Nicholas N. DePhillipo
JDJonathan F. Dickens
Jonathan F. Dickens
AAAdam W. Anz
Adam W. Anz
RLRobert LaPrade
Robert LaPrade
➤ Management of chondral lesions of the knee is challenging and requires assessment of several factors including the size and location of the lesion, limb alignment and rotation, and the physical and mental health of the individual patient. ➤ There are a multitude of options to address chondral pathologies of the knee that allow individualized treatment for the specific needs and demands of the patient. ➤ Osteochondral autograft transfer remains a durable and predictable graft option in smaller lesions (<2 cm2) in the young and active patient population. ➤ Both mid-term and long-term results for large chondral lesions (≥3 cm2) of the knee have demonstrated favorable results with the use of osteochondral allograft or matrix-associated chondrocyte implantation. ➤ Treatment options for small lesions (<2 cm2) include osteochondral autograft transfer and marrow stimulation and/or microfracture with biologic adjunct, while larger lesions (≥2 cm2) are typically treated with osteochondral allograft transplantation, particulated juvenile articular cartilage, or matrix-associated chondrocyte implantation. ➤ Emerging technologies, such as allograft scaffolds and cryopreserved allograft, are being explored for different graft sources to address complex knee chondral pathology; however, further study is needed.

1 October 2020 in Orthopaedic Journal of Sports Medicine
Verified
Journal Article
Open access
PDF file
FGFlávio Luís Garcia
Flávio Luís Garcia
BWBrady T. Williams
Brady T. Williams
EPEvan M. Polce
Evan M. Polce
DHDaniel B. Heller
Daniel B. Heller
ZAZachary S. Aman
Zachary S. Aman
JCJorge Chahla
Jorge Chahla
Despite its increasing use in the management of musculoskeletal conditions, questions remain regarding the preparation methods of platelet-rich plasma (PRP) and its clinical applications for intra-articular hip disorders, including femoroacetabular impingement syndrome (FAIS), labral pathology, and osteoarthritis (OA). To systematically review and assess the preparation methods and clinical outcomes from randomized clinical trials (RCTs) on the use of PRP for intra-articular hip disorders. Systematic review; Level of evidence, 2. A systematic review in accordance with the 2009 PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines was performed in September 2019. The Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, PubMed, Ovid Medline, and Embase were queried for studies regarding the use of PRP to treat intra-articular hip disorders. Qualifying articles were English-language RCTs describing the use of PRP for intra-articular hip disorders, either as standalone treatment or surgical augmentation. Two authors independently assessed article eligibility. Data pertaining to patient characteristics, indication for treatment, PRP preparation method, follow-up period, and clinical outcomes were extracted. Study results were qualitatively reported and quantitatively compared using meta-analysis when appropriate. Seven RCTs met inclusion criteria. Four studies described the use of PRP for hip OA and 3 utilized PRP at arthroscopy for FAIS and labral tears. Outcomes after PRP for OA demonstrated improvement in validated patient-reported outcome measures for up to 1 year; however, pooled effect sizes found no statistically significant difference between PRP and hyaluronic acid (HA) regarding pain visual analog scale scores at short-term (≤2 months; P = .27), midterm (4-6 months; P = .85), or long-term (1 year; P = .42) follow-up. When injected at arthroscopy, 1 study reported improved outcomes, 1 reported no difference in outcomes, and 1 reported worse outcomes compared with controls. The meta-analysis demonstrated no statistically significant difference on the modified Harris Hip Score (mHHS) between PRP and control cohorts at a minimum 1-year follow-up. There were considerable deficiencies and heterogeneity in the reporting of PRP preparation methods for both indications. Treatment of OA with PRP demonstrated reductions in pain and improved patient-reported outcomes for up to 1 year. However, there was no statistically significant difference between PRP and HA in pain reduction. Likewise, for FAIS and labral surgery there was no statistically significant difference in mHHS outcomes between patients treated with PRP and controls. Given the limited number of studies and variability in PRP preparations, additional high-quality randomized trials are warranted.

11 April 2019 in Arthroscopy Techniques
Verified
Journal Article
Open access
LPLiam A. Peebles
Liam A. Peebles
ZAZachary S. Aman
Zachary S. Aman
FPFletcher R. Preuss
Fletcher R. Preuss
BSBrian T. Samuelsen
Brian T. Samuelsen
TZTyler J. Zajac
Tyler J. Zajac
MPMatthew T. Provencher
Matthew T. Provencher
Recurrent multidirectional shoulder instability (MDI) is a challenging clinical problem, particularly in the setting of connective tissue diseases, and there is a distinct lack of literature discussing strategies for operative management of this unique patient group. These patients frequently present with significant glenoid bone loss, patulous and abnormal capsulolabral structures, and a history of multiple failed arthroscopic or open instability procedures. Although the precise treatment algorithm requires tailoring to the individual patient, we have shown successful outcomes in correcting recurrent MDI in the setting of underlying connective tissue disorders by means of a modified T‐plasty capsular shift and rotator interval closure in conjunction with distal tibial allograft bony augmentation. The purpose of this Technical Note was to describe a technique that combines a fresh distal tibial allograft for glenoid bony augmentation with a modified T‐plasty capsular shift and rotator interval closure for the management of recurrent shoulder MDI in patients presenting with Ehlers‐Danlos syndrome or other connective tissue disorders after failed Latarjet stabilization. Technique Video: video See video under supplementary data.

1 May 2026 in Video Journal of Sports Medicine
Verified
Journal Article
Open access
SLSamuel G. Lorentz
Samuel G. Lorentz
ZAZachary S. Aman
Zachary S. Aman
BLBrian C. Lau
Brian C. Lau
JWJocelyn R. Wittstein
Jocelyn R. Wittstein
JBJacqueline M. Brady
Jacqueline M. Brady
Background: Anterior cruciate ligament (ACL) injuries are incredibly common, with an annual incidence of 68.6 per 100,000. The Bridge-Enhanced ACL Restoration (BEAR) is a relatively novel technique that combines suture repair of the ligament and a bioactive scaffold implant to bridge the gap between the torn ligament ends. Since the adoption of the BEAR technique, several modifications have been made to the original technique. These modifications are being prospectively studied within the Bridge registry. Indications: ACL tears amenable to repair. Technique Description: The described technique demonstrates 2 common modifications to the original BEAR technique. The first technique passes 2 luggage tag-style sutures onto the ACL stump. These are then passed into a tensionable suture loop and button assembly. This is passed through a femoral tunnel, securing the ACL stump to the femoral footprint. Bridging sutures are attached to the button, passed through the BEAR Implant, and brought through a tibial tunnel. The second demonstrated technique again passes 2 luggage tag style sutures through the ACL stump and secures them to the femoral footprint using a knotless anchor. Bridging sutures are passed through the BEAR Implant, out a tibia tunnel, and fixed to the tibia with another knotless anchor. In both techniques, the preparation of the BEAR Implant is the same and is completed without arthroscopic visualization. Results: In our experience, patients undergoing BEAR with real-world technique modifications have achieved successful outcomes. The Bridge registry has prospectively followed these patients and has published their early results. With the first 100 patients, they showed an ACL retear rate of 5% at 2 years. Furthermore, there has been a low rate of adverse events, and 61% of patients have been able to return to sport at 9 months. Discussion/Conclusion: Several technical modifications have been developed for the use of the BEAR Implant in ACL repair. These approaches demonstrate promising early outcomes and enable surgeons to tailor the procedure according to their preferences and level of expertise. Patient Consent Disclosure Statement: The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.

1 May 2026 in Video Journal of Sports Medicine
Verified
Journal Article
Open access
ZAZachary S. Aman
Zachary S. Aman
SLSamuel G. Lorentz
Samuel G. Lorentz
RTRobert T. Tisherman
Robert T. Tisherman
JWJocelyn R. Wittstein
Jocelyn R. Wittstein
Background: Extensor mechanism tendon ruptures, including the quadriceps and patellar tendons, are devastating injuries that most often require acute surgical repair to restore knee mechanics and function. There are 2 well-described categories of quadriceps repair techniques, including superior pole suture anchor repairs and transosseous repairs, with recent studies reporting similar overall outcomes. However, failure rates have been reported to be as high as 18% and 21%, respectively. Indications: Extensor mechanism ruptures. Technique Description: The described technique utilizes 2 transosseous patellar tunnels. Retensionable all-suture anchor loops are then passed from the distal cortex to the near cortex, setting the suture anchors at the distal cortex. A Krakow stitch is passed from proximal to distal along the medial tendon, through the suture loop, and then distal to proximal through the central tendon and tied. This is repeated for the lateral half of the tendon. The suture loops are then tensioned to reduce the quadriceps tendon to the patella. The knee is cycled to remove creep from the Krakow suture, and the anchors are retensioned as needed to avoid gapping. This technique can also be utilized for patellar tendon ruptures in a similar fashion, with passage of the loops from proximal to distal and setting of the all-suture implant at the superior pole. Results: In our experience, patients undergoing extensor mechanism repair with knotless retensionable all-suture anchors have achieved successful outcomes. The transosseous adjustable all-suture anchor has been shown to be biomechanically superior to a traditional transosseous suture repair, with significantly less gap formation, higher load-to-failure, and greater stiffness. Furthermore, the adjustable knotless anchor allows retensioning that may improve compression, minimize laxity both intra- and postoperatively, and allow more aggressive flexion range of motion during the early postoperative course. The all-suture anchor may also potentially limit complications related to hardware irritation when metal buttons are used for bicortical fixation or hard-bodied anchors are utilized at the superior pole. Discussion/Conclusion: Transosseous retensionable all-suture anchors offer an alternative high- strength construct for extensor mechanism repairs, with a unique ability to minimize creep within repair constructs intraoperatively. Patient Consent Disclosure Statement: The author(s) attests that consent has been obtained from any patient(s) appearing in this publication. If the individual may be identifiable, the author(s) has included a statement of release or other written form of approval from the patient(s) with this submission for publication.